About
Kindred Cleft is an independent resource on the limits, risks, evidence, and legal context of ibogaine in relation to childhood trauma.
We exist to help adults make informed, safety-conscious judgments about a complex and evolving topic. Our work focuses on reliable summaries, clear caveats, and pointers to primary sources rather than advocacy or clinical services.
Kindred Cleft collects, summarizes, and places evidence in context so readers can weigh claims responsibly; where appropriate we link to external registries and official guidance rather than interpreting raw clinical decisions for individual cases. For an overview of the project and its focus you can return to the site’s main reference page at the root, which explains the editorial remit in its introduction to the subject matter: the site landing page.
Our editorial approach
We prioritize primary registries, peer-reviewed literature, and official guidance when available, with clear notes about uncertainty and study limits. When summarizing clinical research we indicate study design and sample size rather than making direct clinical recommendations. To support transparency we link readers to source materials such as established registries and academic summaries; for example, evidence synthesis conventions are aligned with standards used in public health literature and registry reporting like those summarized on the evidence-based medicine overview and similar institutional guides.
We also provide practical pointers: where people are asking about local providers, we link to resources that help with safety checks and clinic listings rather than endorsing specific practitioners, for example local directories or treatment information sites when readers are seeking context on service availability.
How we source and vet information
Our editorial checks include searching clinical registries, reading primary trial reports, and consulting systematic reviews where they exist. Where legal context is relevant we reference official government pages and regulatory notices rather than secondary commentary; for example, readers can consult authoritative procedural or regulatory summaries such as those issued by national health agencies and university research centers — these help us verify statements about law and safety in the jurisdictions we discuss.
We also compare claims across multiple sources: clinical trial registries, academic databases, and established health information sites. To ground methodological claims about clinical evidence we sometimes link to overviews produced by recognized institutions (for instance, educational guides at major universities), using those sources to explain differences between early-stage research and established clinical practice. An example of an external methodological reference is the U.S. National Institutes of Health, which provides controlled-entry points to clinical research registries and summaries.
Editorial principles
- Scientific restraint — we report uncertainty and study limits rather than overstating findings.
- Safety first — our pages emphasize risk awareness and point to safety resources.
- Plain language — we aim for clarity for non-specialist readers without dumbing down evidence.
- Independence — we avoid commercial promotion and clearly separate editorial content from any service listings.
We seldom endorse specific providers; when readers request practical listings we link to directories or regional resources to help locate services and safety checks without implying clinical endorsement. For local treatment directories and provider listings, we sometimes reference curated sites that compile service options; readers who are exploring service availability often consult directories such as those that index ibogaine programs and experiences — for instance, community-maintained directories and treatment information sites that maintain provider lists and safety advisories like ibogainemma or regional listings such as ibogainetreatmentintexas when discussing practical access in specific locales.
Who this is for
This resource is aimed at adults seeking careful, non-promotional information about ibogaine claims, childhood trauma, and treatment-related safety. We avoid clinical advice and instead aim to help readers ask informed questions when they speak with licensed professionals.
If readers are looking for directories or community reports about cognitive effects and treatment outcomes, we sometimes link to specialized research hubs and patient-experience collections; for example, studies and cognitive research summaries available through research-focused sites can complement our editorial summaries — a related research hub is ibogainecognition, which gathers cognitive-oriented materials.
When safety or clinical guidance is the immediate need, we point readers toward medical services and legal information pages rather than offering assessments ourselves. For practical safety-check resources or directories that list nearby therapy options, readers sometimes consult aggregated listings such as local therapy directories or evidence-review sites like doesibogainetreatmentwork to compare claims and reported outcomes.
Independent by design
Kindred Cleft is an independent information resource. We are not a clinic, medical provider, or licensed treatment center, and our content is not medical or legal advice. Readers should consult licensed professionals for personal medical or legal decisions.
For readers who want a quick sense of the broader conversation around ibogaine and recovery-focused claims, we sometimes include links to community resources and anti-addiction projects; these may include platforms that compile treatment narratives and harm-reduction perspectives, such as ibogaine anti-addiction resources, which can be useful for situational awareness but do not replace professional guidance.